Showing results (201-210 of 212) with videos related to
Sort By:
Pageof 22
Pharmaceuticals (Basel, Switzerland)|June 11, 2015
Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2Faten Alchab, Laurent Ettouati, Zouhair Bouaziz, et al.Blood|December 4, 2015
Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interactionSagar Uttarkar, Emilie Dassé, Anna Coulibaly, et al.Drug Design, Development and Therapy|July 15, 2015
Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activityGustavo Jabor Gozzi, Zouhair Bouaziz, Evelyn Winter, et al.Journal of Medicinal Chemistry|October 2, 2014
Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2Gustavo Jabor Gozzi, Zouhair Bouaziz, Evelyn Winter, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 5, 2014
Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compoundsZouhair Bouaziz, Samar Issa, Jacques Gentili, et al.Glia|September 7, 2019
A modified flavonoid accelerates oligodendrocyte maturation and functional remyelinationWeiping Su, Steven Matsumoto, Fatima Banine, et al.European Journal of Medicinal Chemistry|November 23, 2020
Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2Nathalie Guragossian, Billel Belhani, Alexis Moreno, et al.Archiv Der Pharmazie|August 3, 2026
Targeting Human Protein Kinase CK2 by a Library of Indeno[1,2-b]Indoles: Contribution of Thermal Shift Assay to Pre-Screening and Co-Crystallization to Post-ScreeningMatheus M Guimarães, Christian Werner, Belen Leroy, et al.Scientific Reports|January 20, 2021
Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indolesDiogo Henrique Kita, Nathalie Guragossian, Ingrid Fatima Zattoni, et al.ACS Central Science|June 1, 2022
Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 DimerizationSanil Bhatia, Lukas Spanier, David Bickel, et al.Pageof 22